LYCOS RETRIEVER 
Disease: Treatments
built 629 days ago
The FDA has recently approved use of the drug Tysabri for the treatment of Crohn's disease. The drug already is sold for multiple sclerosis with tight restrictions and a strong warning about a potentially fatal brain infection. The companies must put similar limits on sales for Crohn's disease, the Food and Drug Administration said. Read more.
Source:
Valeant Pharmaceuticals International (NYSE: VRX) is a global, publicly traded, research-based specialty pharmaceutical company that discovers, develops, manufactures and markets products primarily in the areas of neurology, infectious disease and dermatology. More information about Valeant can be found at http://www.valeant.com. Valeant is the maker of Zelapar(R) (selegiline HCl), the first Parkinson's disease treatment to use a novel oral delivery system called Zydis(R) Technology, which allows the tablets to dissolve within seconds in the mouth and deliver more active drug at a lower dose.
Source:
Because it is a chronic disease, RA continues indefinitely and may not go away. Frequent flares in disease activity can occur. RA is a systemic disease, which means it can affect other organs in the body. Early diagnosis and treatment of RA is critical if you want to continue living a productive lifestyle. Studies have shown that early aggressive treatment of RA can limit joint damage, which in turn limits loss of movement, decreased ability to work, higher medical costs and potential surgery.
Source:
MORE ABOUT
Treatments